Clinical trial NCT05295784 - References

Acute Kidney Injury — PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia

Citation(s)

•   AlGadeeb K, Qaraqei M, Algadeeb R, Faqeehi H, Al-Matary A
  Prediction of risk factors and outcomes of neonatal acute kidney injury. J Nephrol. 2021 Oct;34(5):1659-1668. doi: 10.1007/s40620-021-01130-x. Epub 2021 Sep 1. Erratum In: J Nephrol. 2021 Sep 15;:
•   Aranda JV, Beharry KD
  Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns. Semin Fetal Neonatal Med. 2020 Dec;25(6):101183. doi: 10.1016/j.siny.2020.101183. Epub 2020 Nov 26.
•   Aranda JV, Collinge JM, Zinman R, Watters G
  Maturation of caffeine elimination in infancy. Arch Dis Child. 1979 Dec;54(12):946-9. doi: 10.1136/adc.54.12.946.
•   Aviles-Otero N, Kumar R, Khalsa DD, Green G, Carmody JB
  Caffeine exposure and acute kidney injury in premature infants with necrotizing enterocolitis and spontaneous intestinal perforation. Pediatr Nephrol. 2019 Apr;34(4):729-736. doi: 10.1007/s00467-018-4140-y. Epub 2018 Nov 10.
•   Bhatt GC, Gogia P, Bitzan M, Das RR
  Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review. Arch Dis Child. 2019 Jul;104(7):670-679. doi: 10.1136/archdischild-2018-315805. Epub 2019 Feb 23.
•   CAFCIT (caffeine citrate) Injection, CAFCIT (caffeine citrate) Oral solution, Package insert
  Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20793s1lbl.pdf. Accessed October 30, 2021.
•   Carmody JB, Harer MW, Denotti AR, Swanson JR, Charlton JR
  Caffeine Exposure and Risk of Acute Kidney Injury in a Retrospective Cohort of Very Low Birth Weight Neonates. J Pediatr. 2016 May;172:63-68.e1. doi: 10.1016/j.jpeds.2016.01.051. Epub 2016 Feb 18.
•   Cavallin F, Rubin G, Vidal E, Cainelli E, Bonadies L, Suppiej A, Trevisanuto D
  Prognostic role of acute kidney injury on long-term outcome in infants with hypoxic-ischemic encephalopathy. Pediatr Nephrol. 2020 Mar;35(3):477-483. doi: 10.1007/s00467-019-04406-4. Epub 2019 Dec 11.
•   Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A
  Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit. 2008 Dec;30(6):709-16. doi: 10.1097/FTD.0b013e3181898b6f.
•   Chock VY, Cho SH, Frymoyer A
  Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia. Pediatr Res. 2021 Mar;89(4):974-980. doi: 10.1038/s41390-020-0999-y. Epub 2020 Jun 5.
•   Chock VY, Frymoyer A, Yeh CG, Van Meurs KP
  Renal Saturation and Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia. J Pediatr. 2018 Sep;200:232-239.e1. doi: 10.1016/j.jpeds.2018.04.076. Epub 2018 Jun 1.
•   Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, Herring A, Laughon MM, Carlton D, Hunt CE
  Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr. 2014 May;164(5):992-998.e3. doi: 10.1016/j.jpeds.2013.12.025. Epub 2014 Jan 23. Erratum In: J Pediatr. 2014 May;164(5):1244.
•   Echeverri D, Montes FR, Cabrera M, Galan A, Prieto A
  Caffeine's Vascular Mechanisms of Action. Int J Vasc Med. 2010;2010:834060. doi: 10.1155/2010/834060. Epub 2010 Aug 25. Erratum In: Int J Vasc Med. 2019 Nov 20;2019:7480780.
•   Falcao AC, Fernandez de Gatta MM, Delgado Iribarnegaray MF, Santos Buelga D, Garcia MJ, Dominguez-Gil A, Lanao JM
  Population pharmacokinetics of caffeine in premature neonates. Eur J Clin Pharmacol. 1997;52(3):211-7. doi: 10.1007/s002280050276.
•   Frymoyer A, Van Meurs KP, Drover DR, Klawitter J, Christians U, Chock VY
  Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Pediatr Res. 2020 Dec;88(6):871-877. doi: 10.1038/s41390-020-01140-8. Epub 2020 Sep 12.
•   Gillot I, Gouyon JB, Guignard JP
  Renal effects of caffeine in preterm infants. Biol Neonate. 1990;58(3):133-6. doi: 10.1159/000243252.
•   Harer MW, Askenazi DJ, Boohaker LJ, Carmody JB, Griffin RL, Guillet R, Selewski DT, Swanson JR, Charlton JR; Neonatal Kidney Collaborative (NKC)
  Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study. JAMA Pediatr. 2018 Jun 4;172(6):e180322. doi: 10.1001/jamapediatrics.2018.0322. Epub 2018 Jun 4. Erratum In: JAMA Pediatr. 2018 Jun 1;172(6):599.
•   Jetton JG, Boohaker LJ, Sethi SK, Wazir S, Rohatgi S, Soranno DE, Chishti AS, Woroniecki R, Mammen C, Swanson JR, Sridhar S, Wong CS, Kupferman JC, Griffin RL, Askenazi DJ; Neonatal Kidney Collaborative (NKC)
  Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 2017 Nov;1(3):184-194. doi: 10.1016/S2352-4642(17)30069-X.
•   Kirkley MJ, Boohaker L, Griffin R, Soranno DE, Gien J, Askenazi D, Gist KM; Neonatal Kidney Collaborative (NKC)
  Acute kidney injury in neonatal encephalopathy: an evaluation of the AWAKEN database. Pediatr Nephrol. 2019 Jan;34(1):169-176. doi: 10.1007/s00467-018-4068-2. Epub 2018 Aug 28. Erratum In: Pediatr Nephrol. 2018 Oct 12;:
•   Lee TC, Charles B, Steer P, Flenady V, Shearman A
  Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clin Pharmacol Ther. 1997 Jun;61(6):628-40. doi: 10.1016/S0009-9236(97)90097-7.
•   Lynch NE, Stevenson NJ, Livingstone V, Mathieson S, Murphy BP, Rennie JM, Boylan GB
  The temporal characteristics of seizures in neonatal hypoxic ischemic encephalopathy treated with hypothermia. Seizure. 2015 Dec;33:60-5. doi: 10.1016/j.seizure.2015.10.007. Epub 2015 Oct 23.
•   McPherson C, Neil JJ, Tjoeng TH, Pineda R, Inder TE
  A pilot randomized trial of high-dose caffeine therapy in preterm infants. Pediatr Res. 2015 Aug;78(2):198-204. doi: 10.1038/pr.2015.72. Epub 2015 Apr 9.
•   Perera V, Gross AS, McLachlan AJ
  Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma. Biomed Chromatogr. 2010 Oct;24(10):1136-44. doi: 10.1002/bmc.1419.
•   Rumpel J, Spray BJ, Chock VY, Kirkley MJ, Slagle CL, Frymoyer A, Cho SH, Gist KM, Blaszak R, Poindexter B, Courtney SE
  Urine Biomarkers for the Assessment of Acute Kidney Injury in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia. J Pediatr. 2022 Feb;241:133-140.e3. doi: 10.1016/j.jpeds.2021.08.090. Epub 2021 Sep 20.
•   Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS; Caffeine for Apnea of Prematurity (CAP) Trial Investigators
  Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA. 2012 Jan 18;307(3):275-82. doi: 10.1001/jama.2011.2024.
•   Schmidt B, Roberts RS, Anderson PJ, Asztalos EV, Costantini L, Davis PG, Dewey D, D'Ilario J, Doyle LW, Grunau RE, Moddemann D, Nelson H, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity (CAP) Trial Group
  Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial. JAMA Pediatr. 2017 Jun 1;171(6):564-572. doi: 10.1001/jamapediatrics.2017.0238.
•   Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group
  Caffeine therapy for apnea of prematurity. N Engl J Med. 2006 May 18;354(20):2112-21. doi: 10.1056/NEJMoa054065.
•   Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group
  Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007 Nov 8;357(19):1893-902. doi: 10.1056/NEJMoa073679.
•   Selewski DT, Jordan BK, Askenazi DJ, Dechert RE, Sarkar S
  Acute kidney injury in asphyxiated newborns treated with therapeutic hypothermia. J Pediatr. 2013 Apr;162(4):725-729.e1. doi: 10.1016/j.jpeds.2012.10.002. Epub 2012 Nov 10.
•   Thomson AH, Kerr S, Wright S
  Population pharmacokinetics of caffeine in neonates and young infants. Ther Drug Monit. 1996 Jun;18(3):245-53. doi: 10.1097/00007691-199606000-00005.
•   Vesoulis ZA, McPherson C, Neil JJ, Mathur AM, Inder TE
  Early High-Dose Caffeine Increases Seizure Burden in Extremely Preterm Neonates: A Preliminary Study. J Caffeine Res. 2016 Sep 1;6(3):101-107. doi: 10.1089/jcr.2016.0012.
•   Zanelli S, Buck M, Fairchild K
  Physiologic and pharmacologic considerations for hypothermia therapy in neonates. J Perinatol. 2011 Jun;31(6):377-86. doi: 10.1038/jp.2010.146. Epub 2010 Dec 23.
•   Zappitelli M, Ambalavanan N, Askenazi DJ, Moxey-Mims MM, Kimmel PL, Star RA, Abitbol CL, Brophy PD, Hidalgo G, Hanna M, Morgan CM, Raju TNK, Ray P, Reyes-Bou Z, Roushdi A, Goldstein SL
  Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop. Pediatr Res. 2017 Oct;82(4):569-573. doi: 10.1038/pr.2017.136. Epub 2017 Jul 11. No abstract available.

Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia

Details for clinical trial NCT05295784